BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2568026)

  • 1. DNA-DR typing shows HLA-DRw11 RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma.
    Dunckley H; Jazwinska EC; Gatenby PA; Serjeantson SW
    Tissue Antigens; 1989 Mar; 33(3):418-20. PubMed ID: 2568026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DRw11, DQw7 has four cellular subtypes revealed by homozygous typing cells and undetected by restriction fragment length polymorphism.
    Freidel AC; Gebuhrer L; Betuel H; Farre A; Labonne MP; Lambert J
    Hum Immunol; 1991 Mar; 30(3):183-9. PubMed ID: 1676026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRw15 is increased in frequency in Japanese scleroderma patients.
    Jazwinska EC; Olive C; Dunckley H; Naito S; Kuseba T; Serjeantson SW
    Dis Markers; 1990; 8(6):323-6. PubMed ID: 2101346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of DRw52 and its association with DRw11 and DRw12 in South African blacks (Negroes) and individuals of mixed ancestry (Cape coloreds).
    Martell RW; Oudshoorn M; Arendse B; du Toit ED
    Hum Immunol; 1990 May; 28(1):32-8. PubMed ID: 1971270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DQ heterogeneity among HLA-DRw11(5) haplotypes.
    Amar A; Mickelson E; Hansen JA; Nepom GT
    Tissue Antigens; 1986 Nov; 28(5):278-87. PubMed ID: 2881380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of HLA-DRw52 associated antigens using HLA class II allogenotyping.
    Savage DA; Bidwell JL; Cullen C; Bidwell EA; Middleton D
    Tissue Antigens; 1988 Nov; 32(5):278-85. PubMed ID: 2464859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity among DRw13 DQw7 haplotypes as revealed by serology Dw typing and restriction fragment length polymorphism.
    Gebuhrer L; Freidel AC; Lambert J; Labonne MP; Farre A; Betuel H
    Hum Immunol; 1991 Feb; 30(2):85-90. PubMed ID: 1673674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA typing of HLA-DR antigens in systemic lupus erythematosus.
    Dunckley H; Gatenby PA; Serjeantson SW
    Immunogenetics; 1986; 24(3):158-62. PubMed ID: 2875942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancies in serological tissue typing revealed by DNA techniques.
    Middleton D; Savage DA; Cullen C; Martin J
    Transpl Int; 1988 Oct; 1(3):161-4. PubMed ID: 2908097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA DR typing by polymerase chain reaction in Terasaki trays.
    Chia D; Terasaki P; Acalinovich A; Chan H; Balan R
    Transplant Proc; 1995 Feb; 27(1):696-7. PubMed ID: 7879149
    [No Abstract]   [Full Text] [Related]  

  • 11. C4A and C4B null alleles are genetic markers of different types of systemic sclerosis in Japanese patients.
    Takeuchi F; Nabeta H; Hong GH; Matsuta K; Tokunaga K; Tanimoto K; Nakano K
    Clin Exp Rheumatol; 1998; 16(1):55-60. PubMed ID: 9543562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).
    Reveille JD; Owerbach D; Goldstein R; Moreda R; Isern RA; Arnett FC
    J Clin Invest; 1992 Apr; 89(4):1208-13. PubMed ID: 1556182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of RFLP-DR beta and serological HLA-DR typing in 1500 individuals.
    Mytilineos J; Scherer S; Opelz G
    Transplantation; 1990 Nov; 50(5):870-3. PubMed ID: 1978425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RFLP-DR beta and serological HLA-DR typing of 200 kidney recipients and 1000 controls.
    Mytilineos J; Scherer S; Hansen B; Gaweco A; Opelz G
    Transplant Proc; 1990 Aug; 22(4):1911-2. PubMed ID: 1975140
    [No Abstract]   [Full Text] [Related]  

  • 15. [Methods for typing HLA-DR histocompatibility of tissue type antigens based on DNA analysis].
    Bogunia-Kubik K
    Postepy Hig Med Dosw; 1997; 51(5):479-98. PubMed ID: 9489450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serological class II typing with DNA-DR and DNA-DQ typing of kidney donors and recipients.
    Trejaut J; Dunckley H; Sullivan JS; Doran T; Chapman J
    Transplant Proc; 1990 Oct; 22(5):2133. PubMed ID: 1977223
    [No Abstract]   [Full Text] [Related]  

  • 17. Confidence levels assigned to serologic HLA-DR typing predict DNA HLA-DR typing discrepancies.
    Wetzsteon PJ; Head MA; Fletcher LA; Norman DJ
    Transplant Proc; 1992 Dec; 24(6):2483-4. PubMed ID: 1361260
    [No Abstract]   [Full Text] [Related]  

  • 18. HLA-DR typing of renal allograft patients and donors by DNA-RFLP: correlation with pretransplant serotyping.
    Wood N; Joysey V; Bidwell J; Klouda P
    Transplant Proc; 1990 Oct; 22(5):2287. PubMed ID: 1977225
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
    Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
    Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance.
    Duvic M; Hordinsky MK; Fiedler VC; O'Brien WR; Young R; Reveille JD
    Arch Dermatol; 1991 Jan; 127(1):64-8. PubMed ID: 1670917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.